Cite
HARVARD Citation
Hoemberg, M. et al. (2022). Hypercalcemia is a frequent side effect of 13‐cis‐retinoic acid treatment in patients with high‐risk neuroblastoma. Pediatric blood & cancer. 69 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hoemberg, M. et al. (2022). Hypercalcemia is a frequent side effect of 13‐cis‐retinoic acid treatment in patients with high‐risk neuroblastoma. Pediatric blood & cancer. 69 (2), p. n/a. [Online].